ARCHIVES

Industry Groups Lobby for Lower Standards for FDA Approval

This article is from The Cancer Letter archive.

Vol. 37 No. 43 | November 18, 2011

Download PDF Visit The Full Archive

Related Articles

Genentech Says Phase III Trial Shows Avastin Improved PFS For Ovarian Cancer

March 26, 2010

FDA Approves Velcade Injection In Mantle Cell Lymphoma

October 31, 2014

Funding opportunities listed.

February 20, 2004

How Bypass Budget Says NCI Will Spend Its FY 1984 Money

July 16, 1982

Cancer Meetings Listed

November 1, 1996

Grossman Leads Neuro-Oncology Society; NYU Recruits Radiation Oncology Director.

January 14, 2000